The Chinese Market for DNA Sequencing

Published - Jun 2018| Analyst - Jason Chen| Code - BIO152B
The Chinese Market for DNA Sequencing
Single User License: $4,950 Member Price: FREE

Report Highlights

The Chinese market for DNA sequencing totaled $1.2 billion in 2017. The market should total $2.9 billion by 2022, growing at a compound annual growth rate (CAGR) of 19.0% during 2017-2022.

Report Includes

  • 91 tables
  • An in-depth analysis of the Chinese DNA sequencing market, an important sector in life sciences with enormous market potential
  • Analyses of market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Quantification of the DNA sequencing market by product type, platform, customer type, value chain position, analysis type, and region
  • A look at the substantial growth opportunities for industry participants, including consumer and diagnostic sequencing services, bioinformatics, sequence enrichment, benchtop NGS sequencers and consumables, and emerging sequencing instruments
  • Comprehensive discussion covering sequencing technologies, market applications, industry structure, and important clinical sequencing initiatives
  • Company profiles of major Chinese companies in the sequencing industry, including Gene Denovo, IGE Biotechnology Ltd., Pacific Biosciences, Beijing Genomics Institute (BGI), and Adicon Clinical Laboratories, Inc.

Report Scope

The scope of the report includes sequencing technologies, applications, industries, initiatives, markets and companies in China. The markets for sequencing products and services are given for 2016, 2017 and 2022.

This report covers the Chinese sequencing market by workflow, including sample preparation products, sequencing instruments and consumables, informatics and sequencing services. It includes the Chinese sequencing instrument market by platform (i.e., Sanger and next-generation technologies) and by instrument class (i.e., low-throughput, high-throughput, benchtop, handheld).

In this report, “China” refers to Mainland China. This does not include Hong Kong, Macao and Taiwan. Mainland China has a total of 31 province-level regions, including 22 provinces, four province-level municipalities (cities) and five province-level autonomous regions. Important regional markets will be discussed, including Beijing, Shanghai and Guangdong.

More than 100 Chinese companies in the sequencing industry are profiled in this report.

Analyst Credentials

Jason Chen has been an analyst and consultant for the polymer, composite, fiber, textile and energy industries for 15 years. He works as a researcher, writer and/or editor for the American Composites Manufacturers Association (ACMA), China Textile Academy (CTA), China Chemical Fiber Association (CCFA), International Fiber Journal, Filtration News, Platts Emission Daily, Vision Systems Design, Pesticide and Toxic Chemical News and MobileTex. Currently he is the chief scientist of a company endeavoring to reduce China's air and water pollution. He has a degree in Civil Engineering, Chemicals and Advanced Materials from Shantou University.

Select reports include:

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - Sep-2016| Analyst - Jason Chen| Code - BIO152A

Report Highlights

Chinese sequencing market reached $877.6 million in 2015. The market is expected to reach nearly $2.5 billion by 2021 from $1.0 billion in 2016 increasing at a compound annual growth rate (CAGR) of 19.7% from 2016 to 2021.

Report Includes

  • An in-depth analysis of the Chinese sequencing industry, an important industry in life sciences with enormous market potential.
  • Analyses of market trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021.
  • Quantification of the DNA sequencing markets by product type, platform, customer type, value chain position, analysis type and geography.
  • A look at substantial future growth opportunities for industry participants including consumer and diagnostic sequencing services, bioinformatics, sequence enrichment, benchtop NGS sequencers and consumables, and emerging sequencing instruments.
  • Comprehensive discussion covering sequencing technologies, market applications, industry structure, and important clinical sequencing initiatives.
  • Profiles of major players in the Chinese sequencing industry.
RELATED REPORTS
Share This Report